...

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >DIFFERENCES IN COST-EFFECTIVENESS ESTIMATES FOR CHRONIC HEPATITIS C TREATMENT AMONG COHORT MARKOV MODEL, MARKOV MICROSIMULATION AND DISCRETE EVENT SIMULATION

【24h】

DIFFERENCES IN COST-EFFECTIVENESS ESTIMATES FOR CHRONIC HEPATITIS C TREATMENT AMONG COHORT MARKOV MODEL, MARKOV MICROSIMULATION AND DISCRETE EVENT SIMULATION

机译：队列马尔可夫模型，马尔可夫微观模拟和离散事件模拟在慢性肝炎治疗的成本效益估算上的差异

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2016年第7期|共1页
作者
Zhou H. J.; Zhao Y. J.; Wojciech A. C.; Lin L.; Caro J. J.; Moller J.; Dan Y. Y.; Lim B. P.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. DIFFERENCES IN COST-EFFECTIVENESS ESTIMATES FOR CHRONIC HEPATITIS C TREATMENT AMONG COHORT MARKOV MODEL, MARKOV MICROSIMULATION AND DISCRETE EVENT SIMULATION [J] . Zhou H. J., Zhao Y. J., Wojciech A. C., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：队列马尔可夫模型，马尔可夫微观模拟和离散事件模拟在慢性肝炎治疗的成本效益估算上的差异
2. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions. [J] . Kang HY, Ko SK, Liew D Clinical therapeutics . 2009,第12期

机译：马尔可夫模型分析的结果评估朝鲜心血管疾病初步防止心血管疾病的成本效益：韩国个人微观化模型用于心血管健康干预措施。
3. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions. [J] . Kang HY, Ko SK, Liew D Clinical therapeutics . 2009,第12期

机译：马尔可夫模型分析的结果评估朝鲜心血管疾病初步防止心血管疾病的成本效益：韩国个人微观化模型用于心血管健康干预措施。
4. Using a Markov model to evaluate the cost-effectiveness of diabetic foot prevention strategies in Austria [C] . Marion S. Rauner, Kurt Heidenberger, Eva-Maria Pesendorfer International Conference on Health Sciences Simulation . 2004

机译：使用马尔可夫模型来评估奥地利糖尿病足抗策略的成本效益
5. Identifying Optimal Cervical Cancer Prevention Strategies for HIV-positive Women in Senegal, West Africa - Quantification of the Natural History of HPV Among HIV-positive Women and Markov Cohort Cost-Effectiveness Analyses [D] . Whitham, Hilary K. 2015

机译：为西非塞内加尔的HIV阳性妇女确定最佳的宫颈癌预防策略-HIV阳性妇女中HPV自然病史的定量分析和Markov队列成本效益分析
6. Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Model [O] . Steven M. Brunelli, Scott P. Sibbel, David Van Wyck, 2017

机译：柠檬酸铁作为一线磷酸盐粘合剂治疗高磷酸盐血症的净预算影响：马尔可夫微观模拟模型
7. Simulation or cohort models? : Continuous time simulation and discretized Markov models to estimate cost-effectiveness [O] . Soares M., Canto e Castro L. 2010

机译：模拟或队列模型？：连续时间模拟和离散马尔可夫模型，以估计成本效益

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号